Cambridge Investment Research Advisors
HIMS icon

Cambridge Investment Research Advisors’s Hims & Hers Health HIMS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Buy
79,024
+17,152
+28% +$460K 0.01% 1437
2026
Q1 		$1.28M Buy
61,872
+11,226
+22% +$265K ﹤0.01% 1955
2025
Q4 		$1.64M Buy
50,646
+14,497
+40% +$621K ﹤0.01% 1705
2025
Q3 		$2.05M Sell
36,149
-12,245
-25% -$627K 0.01% 1493
2025
Q2 		$2.41M Buy
48,394
+20,966
+76% +$948K 0.01% 1293
2025
Q1 		$810K Sell
27,428
-1,803
-6% -$67K ﹤0.01% 2030
2024
Q4 		$707K Buy
29,231
+1,372
+5% +$34K ﹤0.01% 2150
2024
Q3 		$513K Buy
27,859
+4,642
+20% +$83.1K ﹤0.01% 2397
2024
Q2 		$469K Buy
23,217
+12,798
+123% +$213K ﹤0.01% 2348
2024
Q1 		$161K Buy
+10,419
New +$117K ﹤0.01% 3078

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cambridge Investment Research Advisors's HIMS Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Hims & Hers Health (HIMS) stake by 28% in Q2 2026, buying an estimated $460K and bringing the position to 79,024 shares worth $2.74M. The position accounts for 0.01% of the portfolio, ranked #1437.

Cambridge Investment Research Advisors first reported a position in HIMS in Q1 2024 and has held it in 10 quarters since. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Cambridge Investment Research Advisors held 79,024 shares of Hims & Hers Health worth $2.74M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 17,152 Hims & Hers Health shares in Q2 2026, an estimated $460K.
  • Hims & Hers Health made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1437 holding.
  • Cambridge Investment Research Advisors first reported a position in Hims & Hers Health in Q1 2024 and has held it in 10 quarters since.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.